The Disease Forecasting Company.

Airfinity tracks, simulates and predicts population level disease outcomes in real time to inform decisions that can increase the global life span.

Independent disease forecasting and health intelligence. Cited over 16,000 times in 2023

Analysis & Insights

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity
Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity

New analysis was presented live at the Copenhagen Democracy Summit by Airfinity’s CEO and founder Rasmus Bech Hansen.

Read More →


More from Airfinity

From resistance to resilience: what could the future antibiotic pipeline look like?

Airfinity further expands into APAC with launch of Japan office

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe

Airfinity Named The Financial Times' Healthcare Tech Champion 2023

Airfinity upgrades global biorisk platform

Airfinity named among Bloomberg’s UK Startups to Watch 2023

France faces massive increase in dengue cases by 2030

View All →

In the News

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity

AP News | May 15, 2024

The Missing Factor In Explanations Of China’s Economic Distress: COVID – Part 2: Estimating The True Death Toll

Forbes | May 12, 2024

The truth about AstraZeneca’s Covid vaccine

Independent | May 8, 2024

The terrifying 100-day cough sweeping Britain: Cases are up 3,800 percent with young babies at risk

Daily Mail | May 6, 2024

View All →

A pioneer in predictive health intelligence

Understand

What's happening in a given disease area?

Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.

Predict

Identify the true need for a vaccine or a treatment.

Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.

Act

Maximise impact to save lives

Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.

Analyse, simulate, and predict the changing health landscape

Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.

What our users say?

who

“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force

ifpma

In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”

Iskra Reic, Executive Vice-President
Astrazeneca

Oxford

“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”

Sir John Bell ,
University of Oxford